{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:48:08Z","timestamp":1790660888411,"version":"4.1.0"},"reference-count":40,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"unspecified","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Report effectiveness of selective laser trabeculoplasty (SLT) and topical medical therapy for treatment initiation and escalation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Multicentre, retrospective cohort study covering an observation period of 10 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients with ocular hypertension or primary open-angle glaucoma initiating intraocular pressure (IOP)-lowering therapy, or escalating from a single topical agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measures<\/jats:title>\n                    <jats:p>Kaplan-Meier estimate for duration of treatment success, defined by the time between treatment event to treatment failure, defined as meeting one of the following: a &lt;20% reduction in IOP in comparison to baseline at two consecutive clinic visits; IOP &gt;21\u2009mm Hg at 2 consecutive clinic visits; or subsequent intensification of glaucoma treatment (subsequent increase in medical drops, SLT (re-)treatment, incisional glaucoma therapy).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 4564 eyes (mean baseline IOP 21.8 SD 7.0\u2009mm Hg) of 2708 patients were included. The median time to treatment failure (ie, duration for which treatment success can be expected for 50% of patients) was 1.72 years (95%\u2009CI 1.63 to 1.79) following initiation of a topical agent and 1.35 (95% CI 1.13 to 1.73) years after initial SLT.<\/jats:p>\n                    <jats:p>Following escalation in those already on a single topical agent, the median treatment failure time was 1.32 years (95%\u2009CI 1.23 to 1.44) for 2 topical agents and 1.53 years (95%\u2009CI 1.35 to 2.03) for a single topical agent and SLT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This retrospective analysis reports the real-world effect of SLT and topical medical therapy on IOP and treatment success following the most common treatment scenarios: initiation of IOP-lowering treatment and intensification from a single topical drop. Due to the non-randomised nature of this study, it is not possible to draw firm conclusions regarding the comparative effectiveness of drop and SLT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2025-002151","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T01:15:13Z","timestamp":1753060513000},"page":"e002151","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world outcomes of selective laser trabeculoplasty and medical treatment in primary open-angle glaucoma and ocular hypertension"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2852-6912","authenticated-orcid":false,"given":"Dun Jack","family":"Fu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"},{"name":"UCL Institute of Ophthalmology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishta","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Farwana","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Faes","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos","family":"Lascaratos","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"},{"name":"King's Ophthalmology Research Unit, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Gazzard","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Khawaja","sequence":"additional","affiliation":[{"name":"UCL Institute of Ophthalmology, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3227-2620","authenticated-orcid":false,"given":"Christopher","family":"Hammond","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obeda","family":"Kailani","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, King\u2019s College London, London, UK"},{"name":"King's Ophthalmology Research Unit, King's College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,20]]},"reference":[{"key":"2026010721210725000_10.1.e002151.1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30425-3"},{"key":"2026010721210725000_10.1.e002151.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21899"},{"key":"2026010721210725000_10.1.e002151.3","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.6.701"},{"key":"2026010721210725000_10.1.e002151.4","unstructured":"Glaucoma: diagnosis and management. London National Institute for Health and Care Excellence (NICE."},{"key":"2026010721210725000_10.1.e002151.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2022.09.009"},{"key":"2026010721210725000_10.1.e002151.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32213-X"},{"key":"2026010721210725000_10.1.e002151.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313396"},{"key":"2026010721210725000_10.1.e002151.8","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200604000-00009"},{"key":"2026010721210725000_10.1.e002151.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.11.017"},{"key":"2026010721210725000_10.1.e002151.10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05699-6","article-title":"Real-world data from selective laser trabeculoplasty in Brazil","volume":"12","author":"Abe","year":"2022","journal-title":"Sci Rep"},{"key":"2026010721210725000_10.1.e002151.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05098-z"},{"key":"2026010721210725000_10.1.e002151.12","unstructured":"Jamal A , Haldar S , Twallin S , et al . Real-world experience and outcomes of slt laser used as a first-line treatment in ocular hypertension patients in a united kingdom national health service. Hypertension."},{"key":"2026010721210725000_10.1.e002151.13","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317112"},{"key":"2026010721210725000_10.1.e002151.14","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2023-323708"},{"key":"2026010721210725000_10.1.e002151.15","unstructured":"Team RC . A language and environment for statistical computing. Vienna, Austria R Foundation for Statistical Computing; 2013. Available: http:\/\/www R-project org"},{"key":"2026010721210725000_10.1.e002151.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.07.044"},{"key":"2026010721210725000_10.1.e002151.17","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310877"},{"key":"2026010721210725000_10.1.e002151.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00839.x"},{"key":"2026010721210725000_10.1.e002151.19","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.148510"},{"key":"2026010721210725000_10.1.e002151.20","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.052795"},{"key":"2026010721210725000_10.1.e002151.21","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318218287f"},{"key":"2026010721210725000_10.1.e002151.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-015-0091-2","article-title":"Meta-analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma","volume":"15","author":"Li","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"2026010721210725000_10.1.e002151.23","article-title":"Laser trabeculoplasty for open-angle glaucoma and ocular hypertension","volume":"8","author":"Rolim-de-Moura","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026010721210725000_10.1.e002151.24","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamaophthalmol.2013.7677","article-title":"Effectiveness of intraocular pressure-lowering medication determined by washout","volume":"132","author":"Jampel","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2026010721210725000_10.1.e002151.25","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.ophtha.2013.07.054","article-title":"The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, double-masked, placebo-controlled trial: baseline characteristics","volume":"120","author":"Lascaratos","year":"2013","journal-title":"Ophthalmology"},{"key":"2026010721210725000_10.1.e002151.26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/IJG.0b013e3181e3d2c1","article-title":"SLT and adjunctive medical therapy: a prediction rule analysis","volume":"20","author":"Martow","year":"2011","journal-title":"J Glaucoma"},{"key":"2026010721210725000_10.1.e002151.27","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.062414"},{"key":"2026010721210725000_10.1.e002151.28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/jamaophthalmol.2013.7651","article-title":"Resident-performed selective laser trabeculoplasty in patients with open-angle glaucoma","volume":"132","author":"Greninger","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2026010721210725000_10.1.e002151.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2019.04.012"},{"key":"2026010721210725000_10.1.e002151.30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/IJG.0000000000002466","article-title":"Selective Laser Trabeculoplasty Versus Medical Therapy for the Treatment of Open Angle Glaucoma or Ocular Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"33","author":"Chavez","year":"2024","journal-title":"J Glaucoma"},{"key":"2026010721210725000_10.1.e002151.31","first-page":"29","article-title":"An evaluation of how glaucoma patients use topical medications: a pilot study","volume":"105","author":"Tsai","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2026010721210725000_10.1.e002151.32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/eye.2000.197","article-title":"Compliance and viewpoint of glaucoma patients in Greece","volume":"14 Pt 5","author":"Konstas","year":"2000","journal-title":"Eye (Lond)"},{"key":"2026010721210725000_10.1.e002151.33","doi-asserted-by":"publisher","DOI":"10.1089\/10807680260362687"},{"key":"2026010721210725000_10.1.e002151.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00467-1"},{"key":"2026010721210725000_10.1.e002151.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.004"},{"key":"2026010721210725000_10.1.e002151.36","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00347-016-0332-7","article-title":"Possibilities and limitations of eye drops for glaucoma therapy","volume":"113","author":"Lanzl","year":"2016","journal-title":"Ophthalmologe"},{"key":"2026010721210725000_10.1.e002151.37","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.085522"},{"key":"2026010721210725000_10.1.e002151.38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ogla.2022.08.007","article-title":"Burden of Glaucoma in the United Kingdom: A Multicenter Analysis of United Kingdom Glaucoma Services","volume":"6","author":"Fu","year":"2023","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721210725000_10.1.e002151.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.03.029"},{"key":"2026010721210725000_10.1.e002151.40","doi-asserted-by":"publisher","DOI":"10.1198\/000313006X152649"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2025-002151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:22:03Z","timestamp":1767849723000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2025-002151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,20]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjophth-2025-002151"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2025-002151","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}